Global DTaP and Tdap Vaccines Sales Market Report 2021

1 DTaP and Tdap Vaccines Market Overview

• 1.1 DTaP and Tdap Vaccines Product Scope
• 1.2 DTaP and Tdap Vaccines Segment by Type
  • 1.2.1 Global DTaP and Tdap Vaccines Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 DTaP
  • 1.2.3 Td
  • 1.2.4 Tdap
• 1.3 DTaP and Tdap Vaccines Segment by Application
  • 1.3.1 Global DTaP and Tdap Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Adult
  • 1.3.3 Pediatric
• 1.4 DTaP and Tdap Vaccines Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global DTaP and Tdap Vaccines Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global DTaP and Tdap Vaccines Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global DTaP and Tdap Vaccines Price Trends (2016-2027)

2 DTaP and Tdap Vaccines Estimates and Forecasts by Region

• 2.1 Global DTaP and Tdap Vaccines Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global DTaP and Tdap Vaccines Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global DTaP and Tdap Vaccines Sales Market Share by Region (2016-2021)
  • 2.2.2 Global DTaP and Tdap Vaccines Revenue Market Share by Region (2016-2021)
• 2.3 Global DTaP and Tdap Vaccines Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global DTaP and Tdap Vaccines Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global DTaP and Tdap Vaccines Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America DTaP and Tdap Vaccines Estimates and Projections (2016-2027)
  • 2.4.2 Europe DTaP and Tdap Vaccines Estimates and Projections (2016-2027)
  • 2.4.3 China DTaP and Tdap Vaccines Estimates and Projections (2016-2027)
  • 2.4.4 Japan DTaP and Tdap Vaccines Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia DTaP and Tdap Vaccines Estimates and Projections (2016-2027)
  • 2.4.6 India DTaP and Tdap Vaccines Estimates and Projections (2016-2027)

3 Global DTaP and Tdap Vaccines Competition Landscape by Players

• 3.1 Global Top DTaP and Tdap Vaccines Players by Sales (2016-2021)
• 3.2 Global Top DTaP and Tdap Vaccines Players by Revenue (2016-2021)
• 3.3 Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DTaP and Tdap Vaccines as of 2020)
• 3.4 Global DTaP and Tdap Vaccines Average Price by Company (2016-2021)
• 3.5 Manufacturers DTaP and Tdap Vaccines Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global DTaP and Tdap Vaccines Market Size by Type

• 4.1 Global DTaP and Tdap Vaccines Historic Market Review by Type (2016-2021)
  • 4.1.1 Global DTaP and Tdap Vaccines Sales Market Share by Type (2016-2021)
  • 4.1.2 Global DTaP and Tdap Vaccines Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global DTaP and Tdap Vaccines Price by Type (2016-2021)
• 4.2 Global DTaP and Tdap Vaccines Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Type (2022-2027)
  • 4.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global DTaP and Tdap Vaccines Price Forecast by Type (2022-2027)

5 Global DTaP and Tdap Vaccines Market Size by Application

• 5.1 Global DTaP and Tdap Vaccines Historic Market Review by Application (2016-2021)
  • 5.1.1 Global DTaP and Tdap Vaccines Sales Market Share by Application (2016-2021)
  • 5.1.2 Global DTaP and Tdap Vaccines Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global DTaP and Tdap Vaccines Price by Application (2016-2021)
• 5.2 Global DTaP and Tdap Vaccines Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Application (2022-2027)
  • 5.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global DTaP and Tdap Vaccines Price Forecast by Application (2022-2027)

6 North America DTaP and Tdap Vaccines Market Facts & Figures

• 6.1 North America DTaP and Tdap Vaccines Sales by Company
  • 6.1.1 North America DTaP and Tdap Vaccines Sales by Company (2016-2021)
  • 6.1.2 North America DTaP and Tdap Vaccines Revenue by Company (2016-2021)
• 6.2 North America DTaP and Tdap Vaccines Sales Breakdown by Type
  • 6.2.1 North America DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
• 6.3 North America DTaP and Tdap Vaccines Sales Breakdown by Application
  • 6.3.1 North America DTaP and Tdap Vaccines Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America DTaP and Tdap Vaccines Sales Breakdown by Application (2022-2027)

7 Europe DTaP and Tdap Vaccines Market Facts & Figures

• 7.1 Europe DTaP and Tdap Vaccines Sales by Company
  • 7.1.1 Europe DTaP and Tdap Vaccines Sales by Company (2016-2021)
  • 7.1.2 Europe DTaP and Tdap Vaccines Revenue by Company (2016-2021)
• 7.2 Europe DTaP and Tdap Vaccines Sales Breakdown by Type
  • 7.2.1 Europe DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
• 7.3 Europe DTaP and Tdap Vaccines Sales Breakdown by Application
  • 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China DTaP and Tdap Vaccines Market Facts & Figures

• 8.1 China DTaP and Tdap Vaccines Sales by Company
  • 8.1.1 China DTaP and Tdap Vaccines Sales by Company (2016-2021)
  • 8.1.2 China DTaP and Tdap Vaccines Revenue by Company (2016-2021)
• 8.2 China DTaP and Tdap Vaccines Sales Breakdown by Type
  • 8.2.1 China DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
  • 8.2.2 China DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
• 8.3 China DTaP and Tdap Vaccines Sales Breakdown by Application
  • 8.3.1 China 158 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 158 Sales Breakdown by Application (2022-2027)

9 Japan DTaP and Tdap Vaccines Market Facts & Figures

• 9.1 Japan DTaP and Tdap Vaccines Sales by Company
  • 9.1.1 Japan DTaP and Tdap Vaccines Sales by Company (2016-2021)
  • 9.1.2 Japan DTaP and Tdap Vaccines Revenue by Company (2016-2021)
• 9.2 Japan DTaP and Tdap Vaccines Sales Breakdown by Type
  • 9.2.1 Japan DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
• 9.3 Japan DTaP and Tdap Vaccines Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia DTaP and Tdap Vaccines Market Facts & Figures

• 10.1 Southeast Asia DTaP and Tdap Vaccines Sales by Company
  • 10.1.1 Southeast Asia DTaP and Tdap Vaccines Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia DTaP and Tdap Vaccines Revenue by Company (2016-2021)
• 10.2 Southeast Asia DTaP and Tdap Vaccines Sales Breakdown by Type
  • 10.2.1 Southeast Asia DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia DTaP and Tdap Vaccines Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India DTaP and Tdap Vaccines Market Facts & Figures

• 11.1 India DTaP and Tdap Vaccines Sales by Company
  • 11.1.1 India DTaP and Tdap Vaccines Sales by Company (2016-2021)
  • 11.1.2 India DTaP and Tdap Vaccines Revenue by Company (2016-2021)
• 11.2 India DTaP and Tdap Vaccines Sales Breakdown by Type
  • 11.2.1 India DTaP and Tdap Vaccines Sales Breakdown by Type (2016-2021)
  • 11.2.2 India DTaP and Tdap Vaccines Sales Breakdown by Type (2022-2027)
• 11.3 India DTaP and Tdap Vaccines Sales Breakdown by Application
  • 11.3.1 India DTaP and Tdap Vaccines Sales Breakdown by Application (2016-2021)
  • 11.3.2 India DTaP and Tdap Vaccines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in DTaP and Tdap Vaccines Business

• 12.1 Sanofi Pasteur
  • 12.1.1 Sanofi Pasteur Corporation Information
  • 12.1.2 Sanofi Pasteur Business Overview
  • 12.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
  • 12.1.5 Sanofi Pasteur Recent Development
• 12.2 GlaxoSmithKline
  • 12.2.1 GlaxoSmithKline Corporation Information
  • 12.2.2 GlaxoSmithKline Business Overview
  • 12.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Products Offered
  • 12.2.5 GlaxoSmithKline Recent Development
• 12.3 Protein Sciences Corporation
  • 12.3.1 Protein Sciences Corporation Corporation Information
  • 12.3.2 Protein Sciences Corporation Business Overview
  • 12.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Products Offered
  • 12.3.5 Protein Sciences Corporation Recent Development
• 12.4 Novartis AG
  • 12.4.1 Novartis AG Corporation Information
  • 12.4.2 Novartis AG Business Overview
  • 12.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Novartis AG DTaP and Tdap Vaccines Products Offered
  • 12.4.5 Novartis AG Recent Development
• 12.5 Seqirus
  • 12.5.1 Seqirus Corporation Information
  • 12.5.2 Seqirus Business Overview
  • 12.5.3 Seqirus DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Seqirus DTaP and Tdap Vaccines Products Offered
  • 12.5.5 Seqirus Recent Development
• 12.6 Merck Sharp & Dohme Corp
  • 12.6.1 Merck Sharp & Dohme Corp Corporation Information
  • 12.6.2 Merck Sharp & Dohme Corp Business Overview
  • 12.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Products Offered
  • 12.6.5 Merck Sharp & Dohme Corp Recent Development
• 12.7 Astellas Pharma US, Inc
  • 12.7.1 Astellas Pharma US, Inc Corporation Information
  • 12.7.2 Astellas Pharma US, Inc Business Overview
  • 12.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Products Offered
  • 12.7.5 Astellas Pharma US, Inc Recent Development
• 12.8 Pfizer Inc
  • 12.8.1 Pfizer Inc Corporation Information
  • 12.8.2 Pfizer Inc Business Overview
  • 12.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Pfizer Inc DTaP and Tdap Vaccines Products Offered
  • 12.8.5 Pfizer Inc Recent Development
• 12.9 Johnson & Johnson
  • 12.9.1 Johnson & Johnson Corporation Information
  • 12.9.2 Johnson & Johnson Business Overview
  • 12.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Johnson & Johnson DTaP and Tdap Vaccines Products Offered
  • 12.9.5 Johnson & Johnson Recent Development
• 12.10 Lanzhou Institute of Biological Products Co., Ltd
  • 12.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
  • 12.10.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
  • 12.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Products Offered
  • 12.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
• 12.11 AstraZeneca
  • 12.11.1 AstraZeneca Corporation Information
  • 12.11.2 AstraZeneca Business Overview
  • 12.11.3 AstraZeneca DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 AstraZeneca DTaP and Tdap Vaccines Products Offered
  • 12.11.5 AstraZeneca Recent Development
• 12.12 Emergent BioSolutions Inc
  • 12.12.1 Emergent BioSolutions Inc Corporation Information
  • 12.12.2 Emergent BioSolutions Inc Business Overview
  • 12.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Emergent BioSolutions Inc DTaP and Tdap Vaccines Products Offered
  • 12.12.5 Emergent BioSolutions Inc Recent Development

13 DTaP and Tdap Vaccines Manufacturing Cost Analysis

• 13.1 DTaP and Tdap Vaccines Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of DTaP and Tdap Vaccines
• 13.4 DTaP and Tdap Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 DTaP and Tdap Vaccines Distributors List
• 14.3 DTaP and Tdap Vaccines Customers

15 Market Dynamics

• 15.1 DTaP and Tdap Vaccines Market Trends
• 15.2 DTaP and Tdap Vaccines Drivers
• 15.3 DTaP and Tdap Vaccines Market Challenges
• 15.4 DTaP and Tdap Vaccines Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List